US 11013774
Methods of heat inactivation of adenovirus
granted A61KA61K35/761
Quick answer
US patent 11013774 (Methods of heat inactivation of adenovirus) held by Ultragenyx Pharmaceutical Inc. expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ultragenyx Pharmaceutical Inc.
- Grant date
- Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K35/761